ContractSecurities Purchase Agreement • October 15th, 2013 • Regen BioPharma Inc • California
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of , by and between Regen Biopharma, Inc. , a Nevada corporation, with headquarters located at 4700 Spring Street, Suite 304,La Mesa California, 91942, (the “Company”), and ASC Recap LLC, a Connecticut Limited Liability Company, with its address at 90 Grove Street, Suite 108, Ridgefield CT 06877(the “Buyer”).
WORLDWIDE INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT DATED May 1, 2013 This Intellectual Property Assignment Agreement (“Agreement”) is entered into on May 1, 2013 by and between Dr. Wei Ping Min (“Assignor”), an individual residing at 84 Hesketh St,...Intellectual Property Assignment Agreement • October 15th, 2013 • Regen BioPharma Inc
LICENSE AGREEMENT - EXECUTIONLicense Agreement • October 15th, 2013 • Regen BioPharma Inc • New South Wales
THIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of August 5, 2013 (the “Effective Date”), is made and entered into by and between Benitec Australia Limited, an Australian corporation (ACN 080 299 645) having its registered office at 1-15 Barr Street, Balmain, NSW, Australia 2041, (“Benitec Australia”) and Regen BioPharma, Inc., a United States company having its registered office at 4700 Spring Street, Suite 304, La Mesa, CA 91942 USA, (“Regen BioPharma”). Benitec Australia and Regen BioPharma may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
SERVICE AGREEMENTIndependent Contractor Agreement • October 15th, 2013 • Regen BioPharma Inc • California
This Independent Contractor Agreement (“Agreement”) is entered into this 27th day of July 2013 between Dr. Wei Ping Min (“Min”), a research scientist (hereinafter referred to as “Contractor”) whose address is 84 Hesketh Street, London Ontario N6G5H5, Canada and Regen BioPharma, Inc. (hereinafter referred to as “Client”), a Nevada corporation with offices at 4700 Spring Street, Suite 304, La Mesa, CA 91942.
Exclusive License Agreement Between OHSU and Regen BioPharma, INC For Invention Disclosure 0472Exclusive License Agreement • October 15th, 2013 • Regen BioPharma Inc • Oregon
This Exclusive License Agreement (this "Agreement"), dated and effective as of June 5, 2013 (the "Effective Date"), is between the Oregon Health & Science University, having offices at 0690 SW Bancroft Street, L106TT, Portland, Oregon 97239 ("OHSU"), and Regen BioPharma, Inc., having offices at 4700 Spring St # 304, La Mesa, CA 91942 ("Licensee"). OHSU and Licensee are herein referred to each as a "Party" and collectively as the "Parties."
EMPLOYMENT AGREEMENT BETWEEN BIO-MATRIX SIENTIFIC GROUP, INC. ANDEmployment Agreement • October 15th, 2013 • Regen BioPharma Inc • California
is entered into between Bio-Matrix Scientific Group, Inc., a Delaware corporation, (the "Company") and J. Christopher Mizer ("Employee").
Exclusive Option to Negotiate an Exclusive License Between Oregon Health & Science University and Regen BioPharma, Inc.Exclusive Option to Negotiate an Exclusive License • October 15th, 2013 • Regen BioPharma Inc • Oregon
This Exclusive Option to Negotiate an Exclusive License (this “Agreement”), dated and effective as of June 5, 2012 (the “Effective Date”), is between the Oregon Health & Science University, having offices at 0690 SW Bancroft Street, L106TT, Portland, Oregon 97239 (“OHSU”), and Regen BioPharma, Inc., having offices at 4700 Spring St # 304, La Mesa, CA 91942 (“Optionee”). OHSU and Optionee are herein referred to each as a “Party” and collectively as the “Parties.”
